neelima denduluri, md, offers opinion on the persephone trial in early her2 breast cancer

Published 6 years ago • 93 plays • Length 1:30

Download video MP4
Download video MP3

Similar videos

1:12

neelima denduluri, md, regarding the embraca trial in her2- metastatic breast cancer
1:43

neelima denduluri, md, regarding the monaleesa-7 trial in premenopausal metastatic breast cancer
1:46

neelima denduluri, md, on how the aphinity study could impact treatment of adjuvant breast cancer
0:32

julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
1:02

neelima denduluri, md, elaborates on the sophia trial data in her metastatic breast cancer
1:36

neelima denduluri, md, discusses outcomes from the impassion130 trial
20:11

her2-positive breast cancer—reduce your risk of recurrence | access health
1:03:14

unknowns | episode xxvi
20:14

6 மாசம் வரைக்கும் பால் store பண்ணி வைக்கலாம் | alya manasa about her child birth & weight loss
1:46

dr. murthy on caveats of the persephone trial in breast cancer
1:19

neelima denduluri, md, comments on the role of cdk4/6 inhibitors
0:53

neelima denduluri, md, on the monaleesa-3 study in hr /her2- advanced breast cancer
1:56

persephone: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
1:51

dr. denduluri on treatment approaches in early-stage hr /her2- breast cancer
4:04

the persephone trial: 6 months and 12 months of trastuzumab in breast cancer
1:42

dr. denduluri on the role of neoadjuvant therapy in her2 breast cancer
33:30

neelima denduluri, md -- treatment of triple negative breast cancer
4:27

study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
1:31

dr. loi on immune cells in her2 breast cancer
0:38

neelima denduluri, md, considers whether the results of tailorx are practice-changing
1:54

dr. murthy on her2climb trial results in her2 breast cancer
1:17

neelima denduluri, md, on the outcomes of the sandpiper study presented at asco 2018

Clip.africa.com - Privacy-policy